Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck

Author： Frampton James E.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.15, 2010-10, pp. : 1987-2010

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck and Metastatic Colorectal Cancer

By Blick Stephanie K.A.   Scott Lesley J.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2585-2607

Adis International

Access to resources Recommend Favorite

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3940-3951

Blackwell Publishing

Access to resources Recommend Favorite

Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

By Bagust Adrian  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 439-448

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for squamous-cell carcinoma of the head and neck

By Papaspyrou Giorgos   Werner Jochen A   Dietz Andreas  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 397-409

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata   Gold Kathryn A  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite